Given HCMV’s demonstrated capacity to upregulate PD-L1 in other cancer types, these findings highlight the need to determine which OC cells express PD-L1, where they are located in the TME, whether it is modulated by HCMV, as well as to consider how different therapeutic approaches may interact with these factors to affect OC prognosis. Here, CD274 is linked to cancer.